Full-scale entry into the Medical business through the acquisition of Optos
First written in FY2016. 2 of 4 entries say "Restated". Latest entry: FY2017.
No other company in this theme has enough history to compare yet.
- FY2017AdvancedAnnual report
「In the Medical business, together with UK-based Optos Plc, a subsidiary, we are accelerating the development of products for ultra-widefield (UWF) imaging and optical coherence tomography (OCT), leveraging Nikon’s optical technology and capabilities.」
Following the acquisition of Optos, business operations progressed toward accelerating the development of UWF and OCT products by combining Nikon’s optical technology with Optos’ technology. - FY2017-Q3RestatedAnnual report
「In the Medical business, retinal imaging equipment performed steadily in Japan and Europe, but struggled to grow in the United States.」
The Optos-based Medical business performed steadily in Japan and Europe, while struggling in the United States. - FY2017-Q1RestatedAnnual report
「In the Medical business, Optos Plc’s retinal imaging equipment performed steadily in the United States and Asia-Pacific.」
The Medical business continued to operate following the acquisition of Optos and was described as performing steadily in key regions. - FY2016AchievedAnnual report
「In the Medical business, we made Optos Plc, a leading company in the retinal imaging equipment market, a wholly owned subsidiary and entered the business area in earnest.」
We acquired 100% of the voting rights of Optos Plc on 22 May 2015 and completed the acquisition.